Aristotle Capital Boston’s MedEquities Realty Trust, Inc. MRT Stock Holding History

Aristotle Capital Boston’s Portfolio MRT Stock Details MRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,832,719	Closed	-$20.4M	–	126
2019 Q1	$20.4M	Buy	1,832,719 +677,544	+59%	+$7.33M	0.68%	69
2018 Q4	$7.9M	Buy	1,155,175 +151,451	+15%	+$1.19M	0.65%	71
2018 Q3	$9.76M	Buy	1,003,724 +86,324	+9%	+$915K	0.72%	72
2018 Q2	$10.1M	Sell	917,400 -45,402	-5%	-$469K	0.8%	68
2018 Q1	$10.1M	Buy	962,802 +229,914	+31%	+$2.44M	0.48%	86
2017 Q4	$8.22M	Buy	732,888 +81,654	+13%	+$925K	0.6%	79
2017 Q3	$7.65M	Sell	651,234 -830	-0.1%	-$9.84K	0.69%	68
2017 Q2	$8.23M	Buy	652,064 +75,408	+13%	+$903K	0.92%	45
2017 Q1	$6.46M	Buy	576,656 +208,886	+57%	+$2.33M	0.86%	49
2016 Q4	$4.08M	Buy	367,770 +7,606	+2%	+$85K	0.56%	83
2016 Q3	$4.23M	Buy	+360,164	New	+$4.2M	0.75%	66

Aristotle Capital Boston's MRT Position: Q2 2019 in Review

Aristotle Capital Boston sold out of MedEquities Realty Trust, Inc. (MRT) in Q2 2019, closing a stake of 1,832,719 shares — an estimated $20.4M sold.

Aristotle Capital Boston first reported a position in MRT in Q3 2016 and held it in 11 quarters. The position peaked at $20.4M in Q1 2019. 0 funds tracked by Wall St. Rank hold MRT as of Q2 2019.

Aristotle Capital Boston reported no remaining MedEquities Realty Trust, Inc. position as of Q2 2019 after selling out during the quarter.
Aristotle Capital Boston sold 1,832,719 MedEquities Realty Trust, Inc. shares in Q2 2019, an estimated $20.4M.
Aristotle Capital Boston first reported a position in MedEquities Realty Trust, Inc. in Q3 2016 and held it in 11 quarters.
Aristotle Capital Boston's MedEquities Realty Trust, Inc. position peaked at $20.4M in Q1 2019.
0 funds tracked by Wall St. Rank held MedEquities Realty Trust, Inc. as of Q2 2019.

Based on Aristotle Capital Boston's 13F filing for Q2 2019, filed 14 Aug 2019.